Ignite Creation Date:
2024-05-06 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 2:31 PM
Study NCT ID:
NCT05346354
Status:
RECRUITING
Last Update Posted:
2024-06-04
First Post:
2022-04-20
Brief Title:
Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD
Sponsor:
Alexion Pharmaceuticals Inc
Organization:
Alexion Pharmaceuticals Inc
Organization Data
Organization:
Alexion Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
ALXN1210-NMO-317
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Alexion Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None